|
Re: Funding
|
2
|
Resverlogix Corp.
|
Jun 23, 2017 01:29PM
|
|
When life gives you lemons.....
|
3
|
Resverlogix Corp.
|
Jun 26, 2017 12:27PM
|
|
Re: Merck lands positive PhIII for its CETP drug anacetrapib
|
1
|
Resverlogix Corp.
|
Jun 27, 2017 09:33AM
|
|
Re: Merck lands positive PhIII for its CETP drug anacetrapib
|
3
|
Resverlogix Corp.
|
Jun 27, 2017 10:06AM
|
|
Re: Merck lands positive PhIII for its CETP drug anacetrapib
|
2
|
Resverlogix Corp.
|
Jun 27, 2017 11:23AM
|
|
DSMB says proceed!
|
2
|
Resverlogix Corp.
|
Jun 28, 2017 07:08AM
|
|
Re: Warrants
|
1
|
Resverlogix Corp.
|
Jun 30, 2017 12:54PM
|
|
Re: Warrants
|
2
|
Resverlogix Corp.
|
Jun 30, 2017 05:17PM
|
|
Good news
|
5
|
Resverlogix Corp.
|
Jul 25, 2017 09:14AM
|
|
Hmm...wonder if BMO analyst comes on board
|
2
|
Resverlogix Corp.
|
Jul 25, 2017 09:34AM
|
|
Re: Resverlogix Files 2017 Year-End Disclosure Documents and Announces Plans to Host a Symposium at the European Society of Cardiology Congress 2017
|
6
|
Resverlogix Corp.
|
Jul 25, 2017 07:09PM
|
|
Re: Successful CANTOS Inflammation Trial Supports Rationale for Resverlogix' Ongoing BETonMACE Trial
|
8
|
Resverlogix Corp.
|
Aug 29, 2017 04:55PM
|
|
Re: Could BETonMACE succeed and the FDA still deny approval?
|
6
|
Resverlogix Corp.
|
Sep 15, 2017 07:43AM
|
|
Re: Great Presetation today
|
3
|
Zenith Epigenetics
|
Oct 17, 2017 07:16PM
|
|
Re: A couple from the "Cardiology Top 10" this month.
|
4
|
Resverlogix Corp.
|
Feb 02, 2018 07:30AM
|
|
ESPR got crushed today
|
1
|
Resverlogix Corp.
|
May 02, 2018 05:51PM
|
|
Re: ESPR got crushed today
|
3
|
Resverlogix Corp.
|
May 02, 2018 08:47PM
|
|
Re: ESPR got crushed today
|
2
|
Resverlogix Corp.
|
May 03, 2018 08:06AM
|
|
Re: NIH Halts Large Cardiovascular Inflammation Reduction Trial (CIRT)
|
4
|
Resverlogix Corp.
|
May 22, 2018 07:32AM
|
|
Re: Apabetalone induces apoptosis of latent HIV-1 reservoir cells following viral reactivation
|
11
|
Resverlogix Corp.
|
May 25, 2018 01:39PM
|
